These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19171042)

  • 21. In situ detection of estrogen receptor dimers in breast carcinoma cells in archival materials using proximity ligation assay (PLA).
    Iwabuchi E; Miki Y; Ono K; Onodera Y; Suzuki T; Hirakawa H; Ishida T; Ohuchi N; Sasano H
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):159-169. PubMed ID: 27264933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
    Frogne T; Benjaminsen RV; Sonne-Hansen K; Sorensen BS; Nexo E; Laenkholm AV; Rasmussen LM; Riese DJ; de Cremoux P; Stenvang J; Lykkesfeldt AE
    Breast Cancer Res Treat; 2009 Mar; 114(2):263-75. PubMed ID: 18409071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
    Hyder SM; Liang Y; Wu J
    Int J Cancer; 2009 Sep; 125(5):1045-53. PubMed ID: 19391135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
    Peng J; Jordan VC
    Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.
    Tolhurst RS; Thomas RS; Kyle FJ; Patel H; Periyasamy M; Photiou A; Thiruchelvam PT; Lai CF; Al-Sabbagh M; Fisher RA; Barry S; Crnogorac-Jurcevic T; Martin LA; Dowsett M; Charles Coombes R; Kamalati T; Ali S; Buluwela L
    Breast Cancer Res Treat; 2011 Jul; 128(2):357-68. PubMed ID: 20730598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.
    Moy I; Todorović V; Dubash AD; Coon JS; Parker JB; Buranapramest M; Huang CC; Zhao H; Green KJ; Bulun SE
    Oncogene; 2015 Jan; 34(3):323-33. PubMed ID: 24413080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
    Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
    Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
    Zhang X; Mukerji R; Samadi AK; Cohen MS
    BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].
    Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
    Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.
    Alvarez-Baron CP; Jonsson P; Thomas C; Dryer SE; Williams C
    Mol Endocrinol; 2011 Aug; 25(8):1326-36. PubMed ID: 21680658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
    Rao X; Di Leva G; Li M; Fang F; Devlin C; Hartman-Frey C; Burow ME; Ivan M; Croce CM; Nephew KP
    Oncogene; 2011 Mar; 30(9):1082-97. PubMed ID: 21057537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.
    In SJ; Kim SH; Go RE; Hwang KA; Choi KC
    J Toxicol Environ Health A; 2015; 78(8):492-505. PubMed ID: 25849766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha.
    Zhang Y; Cheng JC; Huang HF; Leung PC
    Biochem Biophys Res Commun; 2013 Nov; 440(4):652-7. PubMed ID: 24099775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells.
    Lan ZJ; Hu Y; Zhang S; Li X; Zhou H; Ding J; Klinge CM; Radde BN; Cooney AJ; Zhang J; Lei Z
    Breast Cancer Res Treat; 2016 Jul; 158(2):263-76. PubMed ID: 27357812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
    Gonzalez TL; Hancock M; Sun S; Gersch CL; Larios JM; David W; Hu J; Hayes DF; Wang S; Rae JM
    Breast Cancer Res Treat; 2020 Apr; 180(3):611-622. PubMed ID: 32067153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.